HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
RFA-NS-22-034 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
12/07/2024 |
Rachel Altshuler, Ph.D. |
Discovery and Development of Natural Products for Cancer Interception and Prevention |
RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed) |
UH3, UG3 |
Clinical Trial Not Allowed |
06/14/2025 |
Altaf Mohammed, Ph.D. |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer |
PAR-22-061 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
01/08/2025 |
Young Kim, Ph.D. |
Basic Research in Cancer Health Disparities |
PAR-21-323 (R21 Clinical Trial Not Allowed) |
R21 |
Clinical Trial Not Allowed |
09/08/2024 |
Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities |
PAR-21-324 (R03 Clinical Trial Not Allowed) |
R03 |
Clinical Trial Not Allowed |
09/08/2024 |
Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities |
PAR-21-322 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
09/08/2024 |
Asad Umar, D.V.M., Ph.D. |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics |
PAR-23-280 (R21 Clinical Trial Not Allowed) |
R21 |
Clinical Trial Not Allowed |
01/08/2027 |
Edward Sauter, M.D., Ph.D. |
Assay Validation of High Quality Markers for Clinical Studies in Cancer |
PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed) |
UH2, UH3 |
Clinical Trial Not Allowed |
10/15/2026 |
Sudhir Srivastava, Ph.D., M.P.H. |
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices |
RFA-EB-22-002 (R18 Clinical Trial Not Allowed) |
R18 |
Clinical Trial Not Allowed |
06/18/2025 |
Rachel Altshuler, Ph.D. |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers |
PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) |
R00, K99 |
Clinical Trial Not Allowed |
10/15/2026 |
Jessica Faupel-Badger, Ph.D., M.P.H. |